Seattle, WA, United States of America

Walter E Stamm


Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Walter E Stamm: Innovator in Urinary Tract Infection Treatments

Introduction

Walter E Stamm, located in Seattle, WA, has made significant contributions to the field of medical science through his innovative inventions. With a total of three patents to his name, Stamm has focused particularly on developing compositions and methods for treating and diagnosing urinary tract infections caused by Escherichia coli.

Latest Patents

Stamm's most recent patents delve into the complexities of urinary tract infections and the techniques used for their detection and prevention. His first patent outlines compositions for treating Escherichia coli urinary tract infections, which emphasizes the detection and use of globosides, including disialosyl galactosyl-globoside (DSGG) and sialosyl galactosyl-globoside (SGG). Furthermore, he has explored stabilized forms of these compounds, in which sialic acid is substituted by KDN.

Additionally, another notable patent involves a method for determining susceptibility to E. coli urinary tract infections. This method includes analyzing epithelial cell samples and vaginal secretions for specific globosides and extended globo structures. His work also addresses the diagnosis of secretors and non-secretors of histo-blood group antigens via assays of vaginal epithelial cells or secretions.

Career Highlights

Throughout his career, Stamm has worked with prominent institutions, including The Biomembrane Institute and the University of Washington. His innovative approaches and research methodologies have greatly advanced the understanding and treatment options available for urinary tract infections, ultimately contributing to better patient care.

Collaborations

Walter E Stamm has collaborated with various professionals in his field, including notable co-workers such as Ann Stapleton and Edward D Nudelman. These collaborations have fostered interdisciplinary approaches to his research, enhancing the impact of his work.

Conclusion

Walter E Stamm exemplifies the spirit of innovation in medical research, focusing on urinary tract infections caused by Escherichia coli. With a robust portfolio of patents and collaborative efforts, his contributions not only advance scientific understanding but also promise significant benefits in treatment strategies. His ongoing work continues to shape the future of medical innovations in this crucial area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…